Cargando…
Metodología del 2º estudio de seroprevalencia en España
Seroprevalence studies are designed in population samples to assess the level and distribution of immunity induced by natural infection of certain infectious agents or by immunization against them. The purpose of the 2(nd) Seroprevalence Study in Spain is to assess the prevalence and distribution of...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ministerio de Sanidad, Consumo y Bienestar social
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560962/ https://www.ncbi.nlm.nih.gov/pubmed/31006772 |
_version_ | 1785117820912140288 |
---|---|
author | Limia Sánchez, Aurora Labrador Cañadas, María Vicenta de Ory Manchón, Fernando Sánchez-Cambronero Cejudo, Laura Rodríguez Cobo, Iria Cantero Gudino, Elena Vázquez Moreno, Julio Arce Arnáez, Araceli |
author_facet | Limia Sánchez, Aurora Labrador Cañadas, María Vicenta de Ory Manchón, Fernando Sánchez-Cambronero Cejudo, Laura Rodríguez Cobo, Iria Cantero Gudino, Elena Vázquez Moreno, Julio Arce Arnáez, Araceli |
author_sort | Limia Sánchez, Aurora |
collection | PubMed |
description | Seroprevalence studies are designed in population samples to assess the level and distribution of immunity induced by natural infection of certain infectious agents or by immunization against them. The purpose of the 2(nd) Seroprevalence Study in Spain is to assess the prevalence and distribution of immune status against vaccine-preventable diseases and generated by natural infection by other microorganisms. Pathologies specifically included in the study are: poliomyelitis, diphtheria, tetanus, pertussis, measles, rubella, mumps, varicella, invasive meningococcal disease by serogroup C, hepatitis A, hepatitis B, hepatitis E, hepatitis C and HIV. The study has a similar design of that conducted in 1996, as it is a descriptive cross-sectional study in resident population of 2 to 80 years of age in Spain. Two-stage conglomerate sampling was carried out on the population aged 2 to 80 years living in Spain, with an initial sample size of 10,000 people. The methodology of the study is described in this article. |
format | Online Article Text |
id | pubmed-10560962 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Ministerio de Sanidad, Consumo y Bienestar social |
record_format | MEDLINE/PubMed |
spelling | pubmed-105609622023-10-10 Metodología del 2º estudio de seroprevalencia en España Limia Sánchez, Aurora Labrador Cañadas, María Vicenta de Ory Manchón, Fernando Sánchez-Cambronero Cejudo, Laura Rodríguez Cobo, Iria Cantero Gudino, Elena Vázquez Moreno, Julio Arce Arnáez, Araceli Rev Esp Salud Publica Colaboración Especial Seroprevalence studies are designed in population samples to assess the level and distribution of immunity induced by natural infection of certain infectious agents or by immunization against them. The purpose of the 2(nd) Seroprevalence Study in Spain is to assess the prevalence and distribution of immune status against vaccine-preventable diseases and generated by natural infection by other microorganisms. Pathologies specifically included in the study are: poliomyelitis, diphtheria, tetanus, pertussis, measles, rubella, mumps, varicella, invasive meningococcal disease by serogroup C, hepatitis A, hepatitis B, hepatitis E, hepatitis C and HIV. The study has a similar design of that conducted in 1996, as it is a descriptive cross-sectional study in resident population of 2 to 80 years of age in Spain. Two-stage conglomerate sampling was carried out on the population aged 2 to 80 years living in Spain, with an initial sample size of 10,000 people. The methodology of the study is described in this article. Ministerio de Sanidad, Consumo y Bienestar social 2019-04-22 /pmc/articles/PMC10560962/ /pubmed/31006772 Text en https://creativecommons.org/licenses/by-nc-nd/3.0/Este es un artículo publicado en acceso abierto bajo una licencia Creative Commons |
spellingShingle | Colaboración Especial Limia Sánchez, Aurora Labrador Cañadas, María Vicenta de Ory Manchón, Fernando Sánchez-Cambronero Cejudo, Laura Rodríguez Cobo, Iria Cantero Gudino, Elena Vázquez Moreno, Julio Arce Arnáez, Araceli Metodología del 2º estudio de seroprevalencia en España |
title | Metodología del 2º estudio de seroprevalencia en España |
title_full | Metodología del 2º estudio de seroprevalencia en España |
title_fullStr | Metodología del 2º estudio de seroprevalencia en España |
title_full_unstemmed | Metodología del 2º estudio de seroprevalencia en España |
title_short | Metodología del 2º estudio de seroprevalencia en España |
title_sort | metodología del 2º estudio de seroprevalencia en españa |
topic | Colaboración Especial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560962/ https://www.ncbi.nlm.nih.gov/pubmed/31006772 |
work_keys_str_mv | AT limiasanchezaurora metodologiadel2oestudiodeseroprevalenciaenespana AT labradorcanadasmariavicenta metodologiadel2oestudiodeseroprevalenciaenespana AT deorymanchonfernando metodologiadel2oestudiodeseroprevalenciaenespana AT sanchezcambronerocejudolaura metodologiadel2oestudiodeseroprevalenciaenespana AT rodriguezcoboiria metodologiadel2oestudiodeseroprevalenciaenespana AT canterogudinoelena metodologiadel2oestudiodeseroprevalenciaenespana AT vazquezmorenojulio metodologiadel2oestudiodeseroprevalenciaenespana AT arcearnaezaraceli metodologiadel2oestudiodeseroprevalenciaenespana |